Data gathered: December 9
Data Bits
Data Bits | Value / Change | Benchmark | |
---|---|---|---|
Job Posts | N/A | N/A | |
Sentiment | N/A | N/A | |
Webpage traffic | N/A | N/A | |
Employee Rating | N/A | N/A | |
Google Adspend | $ N/A | N/A | |
Google Trends | N/A | N/A | |
Linkedin Employees | N/A | N/A | |
Patents | N/A | N/A | |
4chan Mentions | N/A | N/A | |
Facebook Engagement | N/A | N/A | |
Facebook followers | N/A | N/A | |
Stocktwits Mentions | N/A | N/A | |
Stocktwits Subscribers | N/A | N/A | |
Twitter Followers | N/A | N/A | |
Youtube Subscribers | N/A | N/A | |
Instagram Followers | N/A | N/A | |
News Mentions | N/A | N/A | |
Reddit Mentions | N/A | N/A | |
Business outlook | N/A | N/A |
In the news
Charles River (CRL) Up 19.7% Since Last Earnings Report: Can It Continue?December 8 - Yahoo |
|
Investing in the Aging Population: 3 Healthcare Stocks to WatchDecember 6 - InvestorPlace |
|
Here's Why You Should Retain Charles River (CRL) Stock NowDecember 4 - Yahoo |
|
Creightons swings to half-year profit on cost-cutting measuresDecember 3 - Alliance News |
|
Insider Sell: EVP Joseph Laplume Sells Shares of Charles River Laboratories International Inc (CRL)December 1 - Yahoo Entertainment |
|
Earnings’ Overlooked Role in Powering This RallyDecember 1 - Barron's |
About Charles River Laboratories
Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment and Manufacturing Support.

Price | $204.29 |
Target Price | Sign up |
Market Cap | $10.4B |
Dividend Yield | 0.024 |
Industry | Biotechnology |
Similar companies
Company | Price | AI Score |
---|
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
---|---|---|---|---|---|
Q3 '23 | 1.02B | 225M | 790M | 87M | 180M |
Q2 '23 | 1.05B | 234M | 815M | 97M | 196M |
Q1 '23 | 1.03B | 652M | 378M | 103M | 200M |
Q4 '22 | 1.23B | 246M | 986M | 187M | 316M |
Q3 '22 | 994M | 220M | 773M | 96M | 169M |
Insider Transactions
LaPlume Joseph W filed to sell 23,133 shares at $197.7. December 1 '23 |
Girshick Birgit filed to buy 44,449 shares at $187.8. November 21 '23 |
LaPlume Joseph W filed to sell 24,983 shares at $173.8. November 13 '23 |
WALLMAN RICHARD F filed to buy 1,000 shares at $198.8. August 29 '23 |
LaPlume Joseph W filed to sell 24,983 shares at $216.5. August 14 '23 |